Effects of long-term treatment with desipramine on microtubule proteins in rat cerebral cortex

https://doi.org/10.1016/S0014-2999(97)01140-0Get rights and content

Abstract

The molecular mechanism of the action of antidepressants beyond the receptor level has not yet been elucidated. We have investigated the effects of long-term treatment with desipramine on the phosphorylation state of microtubule-associated protein 2 (MAP2) and microtubule assembly in the rat cerebral cortex. Phosphorylation of MAP2 was detected by immunoblotting after immunoprecipitation of MAP2 in the soluble fraction. The degree of phosphorylation of serine residues of MAP2 was significantly increased after chronic administration of desipramine without changes in the total concentration of MAP2. Microtubule assembly in crude brain extracts was monitored in terms of changes in turbidity measured at 350 nm using a spectrophotometer. Chronic but not acute treatment with desipramine inhibited microtubule assembly, assayed in the presence of a phosphatase inhibitor, calyculin A, whereas the inhibition was completely nullified in the absence of calyculin A. Desipramine had no direct effect on microtubule assembly in vitro. These results raise the possibility that the changes in the degree of phosphorylation of MAP2 and microtubule assembly represent intracellular modifications involved in functional changes elicited by long-term treatment with desipramine.

Introduction

The molecular mechanism of the action of antidepressants beyond the receptor level has not yet been elucidated. Previously, long-term treatment with desipramine, a tricyclic antidepressant drug, was reported to modify the endogenous phosphorylation of microtubule-associated protein 2 (MAP2) in both soluble and crude microtubule fractions of the rat cerebral cortex (Perez et al., 1989). MAP2 is known to be a substrate for several protein kinases such as type II cyclic AMP (cAMP)-dependent protein kinase (Vallee, 1980), Ca2+/calmodulin-dependent protein kinase II (Goldenring et al., 1983; Schulman, 1984) and Ca2+/phospholipid-dependent protein kinase (Akiyama et al., 1986). Several lines of evidence demonstrate that phosphorylation of MAP2 catalyzed by each of these protein kinases results in the inhibition of microtubule assembly in vitro (Jameson et al., 1980; Yamamoto et al., 1985; Hoshi et al., 1988). Thus, it is of interest to determine the effect of administration of antidepressants on microtubule assembly as a potential target for the action of antidepressants. In this study, we investigated the effects of long-term treatment with desipramine on the phosphorylation state of MAP2 as well as microtubule assembly in the rat cerebral cortex.

Section snippets

Antibodies

Monoclonal anti-MAP2 (2a-2b) (mouse IgG1) and anti-MAP1 (mouse IgG1) were obtained from Sigma Chemical (USA). Monoclonal anti-tau (mouse IgG1) was purchased from Chemicon International (USA). Monoclonal anti-α-tubulin (mouse IgG1) and anti-β-tubulin (mouse IgG1) were obtained from Oncogene Science (USA). Monoclonal anti-phosphoserine (mouse IgG1), anti-phosphothreonine (mouse IgG2b) and anti-phosphotyrosine (mouse IgG1) were obtained from Bio-Makor (Israel).

Animals and drug treatments

Adult male Wistar rats (150–200 g)

Effect of chronic desipramine treatment on MAPs phosphorylation

As shown in Fig. 1A (lanes 1 and 2), the anti-MAP2 monoclonal antibody stained a band of molecular weight 280 kDa of protein after immunoprecipitation of MAP2 from the cerebrocortical boiled supernatant fraction and electrophoresis of the immunoprecipitated MAP2. We observed no significant difference in the immunoreactivity of MAP2 between rats treated chronically with saline or desipramine (Fig. 1A and B, lanes 1 and 2). As shown in Fig. 1A and B (lanes 3 and 4), the immunoreactivity of the

Discussion

Although the therapeutic efficacy of antidepressants in the treatment of depression is well established, their precise mechanism of action has not yet been elucidated. A single administration of antidepressants induces an inhibition of monoamine reuptake within minutes to hours, whereas the clinical response to antidepressants usually requires 1 to 3 weeks to become evident (Heninger and Charney, 1987). The dissociation between the acute effect of antidepressants and the delayed onset of

Acknowledgements

We thank Ms. Yuriko Ogawa and Mr. Yuji Gamo for their assistance. This study was supported by a Research Grant for Nervous and Mental Disorders from the Ministry of Health and Welfare, Japan.

References (52)

  • J Perez et al.

    cAMP-dependent phosphorylation of soluble and crude microtubule fractions of rat cerebral cortex after prolonged desmethylimipramine treatment

    Eur. J. Pharmacol. Mol. Pharmacol. Sec.

    (1989)
  • A Qian et al.

    A comparison of microtubule assembly in brain extracts from young and old rats

    Mol. Brain Res.

    (1993)
  • W.E Theurkauf et al.

    Molecular characterization of the cAMP-dependent protein kinase bound to microtubule-associated protein 2

    J. Biol. Chem.

    (1982)
  • S Tsuyama et al.

    Calcium/phospholipid-dependent kinase recognizes sites in microtubule-associated protein 2 which are phosphorylated in living brain and are not accessible to other kinases

    J. Biol. Chem.

    (1986)
  • F Wandosell et al.

    Phosphorylation of tubulin by a calmodulin-dependent protein kinase

    J. Biol. Chem.

    (1986)
  • D.S Charney et al.

    Receptor sensitivity and the mechanism of action of antidepressant treatment

    Arch. Gen. Psychiatry

    (1981)
  • F.J Diez-Guerra et al.

    Rapid dephosphorylation of microtubule-associated protein 2 in the rat brain hippocampus after pentylenetetrazole-induced seizures

    Eur. J. Biochem.

    (1993)
  • F.J Diez-Guerra et al.

    An increase in phosphorylation of microtubule-associated protein 2 accompanies dendrite extension during the differentiation of cultured hippocampal neurones

    Eur. J. Biochem.

    (1995)
  • R.S Duman et al.

    Adaptations of receptor-coupled signal transduction pathways underlying stress- and drug-induced neural plasticity

    J. Nerv. Ment. Dis.

    (1994)
  • A Fellous et al.

    Microtubule assembly in vitro

    Eur. J. Biochem.

    (1977)
  • J.R Goldenring et al.

    Phosphorylation of microtubule-associated protein 2 at distinct sites by calmodulin-dependent and cyclic-AMP-dependent kinases

    J. Neurochem.

    (1985)
  • G.F Hall et al.

    Microtubule destabilization and neurofilament phosphorylation precede dendritic sprouting after close axotomy of lamprey central neurones

    Proc. Natl. Acad. Sci. U.S.A.

    (1991)
  • S Hatta et al.

    Participation of tubulin in the stimulatory regulation of adenylyl cyclase in rat cerebral cortex membranes

    J. Neurochem.

    (1995)
  • Heninger, G.R., Charney, D.S., 1987. Mechanism of action of antidepressant treatments: Implications for the etiology...
  • M Hoshi et al.

    Protein-kinase-C-catalyzed phosphorylation of the microtubule-binding domain of microtubule-associated protein 2 inhibits its ability to induce tubulin polymerization

    Eur. J. Biochem.

    (1988)
  • S.M Hsu et al.

    A comparative study of the peroxidase–antiperoxidase method and an avidin–biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies

    Am. J. Clin. Pathol.

    (1981)
  • Cited by (24)

    • Altered protein kinase A in brain of learned helpless rats: Effects of acute and repeated stress

      2004, Biological Psychiatry
      Citation Excerpt :

      For example, chronic treatment with imipramine, tranylcypromine, or electroconvulsive shock causes the translocation of PKA in rat brain (Nestler et al 1989). In addition, long-term treatment with 5HT- or NE-reuptake inhibitors increases the binding of cAMP to 52-kDa RII subunits of PKA (Mori et al 1998; Perez et al 1991), and Miyamoto et al (1997) demonstrated that long-term desipramine treatment of rats increased phosphorylation of the PKA substrate microtubule-associated protein-2, which may be associated with activation of RII PKA. These findings thus suggest that in depression, functions of PKA may be reduced and antidepressants may alleviate depressive symptoms by increasing the functioning of PKA.

    • Serine/threonine kinases as molecular targets of antidepressants: Implications for pharmacological treatment and pathophysiology of affective disorders

      2001, Pharmacology and Therapeutics
      Citation Excerpt :

      Therefore, it was conceivable that a downstream effect of antidepressant treatment may be a certain degree of microtubule disassembly. This was indeed found by Miyamoto and colleagues (1997), who showed that long-term DMI treatment increased serine phosphorylation of MAP2 in the cerebral cortex (PKA and PKC phosphorylate MAP2 exclusively on serine residues; Walaas & Nairn, 1989). When the assembly of microtubules was investigated, they found that previous treatment of animals with DMI resulted in reduced microtubule nucleation and reduced the initial rate and final extent of microtubule assembly in vitro.

    View all citing articles on Scopus
    View full text